Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.71
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Most Active Equity Options For Midday - Tuesday, Dec. 19
December 19, 2023
Via
Talk Markets
Why Pfizer Stock Is Bouncing Back
December 19, 2023
I think Pfizer stock looks kinda cheap.
Via
The Motley Fool
Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
December 19, 2023
A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) related to seeking fair compensation for infringement of a portfolio of
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts
December 19, 2023
From
Pfizer Inc.
Via
Business Wire
Generis and Userlane Forge Strategic Partnership to Accelerate Digital Transformation in Regulated Industries
December 19, 2023
LONDON - Dec. 19, 2023 - PRLog -- Generis and Userlane today announced a strategic partnership. Generis is the developer of the CARA platform for data, content, and business process management in...
Via
PRLog
Why Pfizer Stock Was a Winner on Monday
December 18, 2023
The company received its latest U.S. regulatory green light.
Via
The Motley Fool
Should You Worry About the Latest Wave of Bad News from Pfizer?
December 17, 2023
In response to the news, Pfizer shares fell to a 10-year low.
Via
The Motley Fool
Could Pfizer Stock Help You Become a Millionaire?
December 16, 2023
Everyone has been talking about this stock, but that alone doesn't make it a good buy.
Via
The Motley Fool
5 of the Safest High-Yield Dividend Stocks to Buy for 2024
December 19, 2023
These supercharged dividend stocks, with yields ranging from 5.4% to 10.5%, offer highly favorable risk-versus-reward profiles for income seekers in the new year.
Via
The Motley Fool
3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?
December 18, 2023
Investors still need to look at the business when searching for stocks to buy at a 52-week low because the business model may be broken.
Via
InvestorPlace
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
Most Active Equity Options For Midday - Monday, Dec. 18
December 18, 2023
Here are the most active equity options for midday.
Via
Talk Markets
Pfizer Dividend Increase
December 15, 2023
Pfizer announced its next dividend of $0.42 per share, a 2.44% increase over the company's previous payout of $0.41.
Via
Talk Markets
Pfizer Inc. (NYSE: PFE) is One of Friday Morning’s Most Active Stocks
December 15, 2023
Via
Investor Brand Network
Exposures
COVID-19
The Pain Continues For Bedraggled Pharma Heavyweight Pfizer
December 15, 2023
Yet another analyst cut expectations and his price target on Pfizer stock Friday.
Via
Investor's Business Daily
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
December 18, 2023
It's no secret that the next couple of years will be slow.
Via
The Motley Fool
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
2024 is going to be a sizzler in the biopharma sector.
Via
The Motley Fool
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF (IBB) was down 7.5% while the S&P 500 was up more than 14%.
Via
Benzinga
Topics
ETFs
2 High-Yield Dividend Stocks That Could Climb 29% and 24% in 2024, According to Wall Street.
December 18, 2023
These dividend payers offer attention-getting yields and a chance for significant growth of your principal investment.
Via
The Motley Fool
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
December 18, 2023
Analysts think these beaten-down stocks could rebound strongly in the new year.
Via
The Motley Fool
Why the dividend investor may take a look at NYSE:PFE.
December 15, 2023
Is PFIZER INC (NYSE:PFE) suited for dividend investing?
Via
Chartmill
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.
Via
InvestorPlace
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.
Via
InvestorPlace
3 S&P 500 Stocks That Are About to Get Absolutely Crushed
December 16, 2023
Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
These stocks could bring investors more than just a lump of coal for Christmas.
Via
The Motley Fool
Exposures
Coal
PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
December 15, 2023
From
Pfizer Inc.
Via
Business Wire
What's Going On With Pfizer Stock?
December 15, 2023
Pfizer, Inc. (NYSE: PFE) shares are trading higher Friday. The stock remains down by more than 11% over the past five days and down by more than 47% year-to-date.
Via
Benzinga
Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review
December 15, 2023
The Dow hit a record high while the S&P 500 and Nasdaq set 2023 bests.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Texas Has Given Birth to Its First and Only Global Publicly Traded Cannabis Company, Cannabis Bioscience International Holdings
December 15, 2023
Houston, Texas--(Newsfile Corp. - December 15, 2023) - On December 5, 2023, Cannabis Bioscience International Holdings (OTC Pink: CBIH) ,...
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Quick list of bargain stocks to end the year
December 15, 2023
Stocks are soaring after a FED dovish pivot, making these value stocks all the more attractive today. Analysts have built up cases as to why they will rally
Via
MarketBeat
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.